Silvia Scriffignano

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Venues

Rheumatology and therapy

Current rheumatology reports

The Journal of rheumatology

Expert review of clinical immunology

University of Campania "Luigi Vanvitelli"

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Campania "Luigi Vanvitelli"

Italy

Specialist Trainee in Rheumatology :: Precision Medicine Department- Rheumatology

Publications

Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and therapy 11 (3) (2024)
Fabio Massimo Perrotta, Stefano Gentileschi, Silvia Scriffignano, Riccardo Terribili, Elena Bianchi, Bruno Frediani, Ennio Lubrano
Difficult-to-Treat Concept in Psoriatic Arthritis: Analysis of 2 Potential Definitions in a Large Group of Patients: A Cross-Sectional Study. The Journal of rheumatology (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review. Current rheumatology reports 26 (9) (2024)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and therapy 11 (3) (2024)
Fabio Massimo Perrotta, Silvia Scriffignano, Paola Triggianese, Mario Ferraioli, Maria Sole Chimenti, Ennio Lubrano
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts. The Journal of rheumatology 51 (3) (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review. Current rheumatology reports 26 (9) (2024)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and therapy 11 (3) (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review. Current rheumatology reports 26 (9) (2024)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and therapy 11 (3) (2024)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and therapy (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review. Current rheumatology reports 26 (9) (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Mauro Fatica, Paola Triggianese, Maria Sole Chimenti, Ennio Lubrano
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? Rheumatology and therapy (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review. Current rheumatology reports 26 (9) (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review. Current rheumatology reports 26 (9) (2024)
Fabio Massimo Perrotta, Silvia Scriffignano, Paola Triggianese, Mario Ferraioli, Maria Sole Chimenti, Ennio Lubrano
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts. The Journal of rheumatology 51 (3) (2024)
Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review. Current rheumatology reports (2024)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis. Rheumatology and therapy (2023)
Silvia Scriffignano, Fabio Massimo Perrotta, Paola Conigliaro, Mauro Fatica, Paola Triggianese, Maria Sole Chimenti, Ennio Lubrano
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis. Rheumatology and therapy (2023)
Ennio Lubrano, Silvia Scriffignano, Kurt de Vlam, Mario Ronga, Fabio Massimo Perrotta, Rik Lories
Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise - a review. RMD open 9 (3) (2023)
Ennio Lubrano, Silvia Scriffignano, Mauro Fatica, Paola Triggianese, Paola Conigliaro, Fabio Massimo Perrotta, Maria Sole Chimenti
Psoriatic Arthritis in Males and Females: Differences and Similarities. Rheumatology and therapy (2023)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective. Rheumatology and therapy 10 (2) (2022)
Fabio Massimo Perrotta, Silvia Scriffignano, Francesco Ciccia, Ennio Lubrano
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and therapy 9 (4) (2022)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective. Rheumatology and therapy 10 (2) (2022)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective. Rheumatology and therapy (2022)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective. Rheumatology and therapy 10 (2) (2022)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective. Rheumatology and therapy 10 (2) (2022)
Ennio Lubrano, Silvia Scriffignano, Romeo Morelli, Fabio Massimo Perrotta
Assessment of Widespread and Extraarticular Pain in Psoriatic Arthritis: A Case-control Study. The Journal of rheumatology 48 (9) (2021)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis. Rheumatology and therapy 8 (3) (2021)
Fabio Massimo Perrotta, Silvia Scriffignano, Ennio Lubrano
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients. Rheumatology and therapy 8 (4) (2021)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Dr. Lubrano, et al reply. The Journal of rheumatology 47 (6) (2020)
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Multimorbidity and comorbidity in psoriatic arthritis - a perspective. Expert review of clinical immunology 16 (10) (2020)

Silvia Scriffignano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Silvia Scriffignano